Literature DB >> 18600319

Distant metastases and synchronous second primary tumors in patients with newly diagnosed oropharyngeal and hypopharyngeal carcinomas: evaluation of (18)F-FDG PET and extended-field multi-detector row CT.

Shu-Hang Ng1, Sheng-Chieh Chan, Chun-Ta Liao, Joseph Tung-Chieh Chang, Sheung-Fat Ko, Hung-Ming Wang, Shu-Chyn Chin, Chin-Yu Lin, Shiang-Fu Huang, Tzu-Chen Yen.   

Abstract

INTRODUCTION: Patients with oropharyngeal or hypopharyngeal squamous cell carcinoma (SCC) have a high risk of having distant metastases or second primary tumors. We prospectively evaluate the clinical usefulness of (18)F-fluoro-2-deoxyglucose positron emission tomography ((18)F-FDG PET), extended-field multi-detector computed tomography (MDCT), and their side-by-side visual correlation for the detection of distant malignancies in these two tumors at presentation.
MATERIALS AND METHODS: A total of 160 patients with SCC of the oropharynx (n = 74) or hypopharynx (n = 86) underwent (18)F-FDG PET and extended-field MDCT to detect distant metastases or second primary tumors. Suspected lesions were investigated by means of biopsy, clinical, or imaging follow-up.
RESULTS: Twenty-six (16.3%) of our 160 patients were found to have distant malignancy. Diagnostic yields of (18)F-FDG PET and MDCT were 12.5% and 8.1%, respectively. The sensitivity of (18)F-FDG PET for detection of distant malignancies was 1.5-fold higher than that of MDCT (76.9% vs. 50.0%, P = 0.039), while its specificity was slightly lower (94.0% vs. 97.8%, P = 0.125). Side-by-side visual correlation of MDCT and (18)F-FDG PET improved the sensitivity and specificity up to 80.8% and 98.5%, respectively, leading to alteration of treatment in 13.1% of patients. A significant difference in survival rates between its positive and negative results was observed.
CONCLUSION: (18)F-FDG PET and extended-field MDCT had acceptable diagnostic yields for detection of distant malignancies in untreated oropharyngeal and hypopharyngeal SCC. (18)F-FDG PET was 1.5-fold more sensitive than MDCT, but had more false-positive findings. Their visual correlation improved the diagnostic accuracy, treatment planning, and prognosis prediction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18600319     DOI: 10.1007/s00234-008-0426-2

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  42 in total

1.  Radiological staging of the chest and abdomen in head and neck squamous cell carcinoma--are computed tomography and ultrasound necessary?

Authors:  E L Nilssen; P Murthy; L McClymont; S Denholm
Journal:  J Laryngol Otol       Date:  1999-02       Impact factor: 1.469

2.  Efficacy of radiologic screening for distant metastases and second primaries in newly diagnosed patients with head and neck cancer.

Authors:  Martin C Jäckel; Andrea Reischl; Peter Huppert
Journal:  Laryngoscope       Date:  2007-02       Impact factor: 3.325

3.  Metastatic patterns in squamous cell cancer of the head and neck.

Authors:  C Kotwall; K Sako; M S Razack; U Rao; V Bakamjian; D P Shedd
Journal:  Am J Surg       Date:  1987-10       Impact factor: 2.565

4.  CT staging and surveillance of the thorax in patients with newly diagnosed and recurrent squamous cell carcinoma of the head and neck: is it necessary?

Authors:  Fergal Glynn; Sinead Brennan; Gerard O'Leary
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-07-08       Impact factor: 2.503

5.  Second primary cancers of the head and neck following treatment of initial primary head and neck cancers.

Authors:  R G Parker; J E Enstrom
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-03       Impact factor: 7.038

6.  FDG PET evaluation of head and neck cancer: value of imaging the thorax.

Authors:  J W Keyes; M Y Chen; N E Watson; K M Greven; W F McGuirt; D W Williams
Journal:  Head Neck       Date:  2000-03       Impact factor: 3.147

7.  Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.

Authors:  Mark K Wax; Larry L Myers; Edward C Gabalski; Syed Husain; Jayakumari M Gona; Hani Nabi
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2002-06

8.  Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?

Authors:  Emmanuel Guardiola; Xavier Pivot; Olivier Dassonville; Gilles Poissonnet; Pierre-Yves Marcy; Josiane Otto; Michel Poudenx; Eric Francois; René-Jean Bensadoun; Antoine Thyss; François Demard; Maurice Schneider
Journal:  Cancer       Date:  2004-11-01       Impact factor: 6.860

9.  FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group.

Authors:  J F Vansteenkiste; S G Stroobants; P J Dupont; P R De Leyn; W F De Wever; E K Verbeken; J L Nuyts; F P Maes; J G Bogaert
Journal:  Eur J Nucl Med       Date:  1998-11

10.  Staging of head and neck squamous cell cancer with extended-field FDG-PET.

Authors:  David L Schwartz; Joseph Rajendran; Bevan Yueh; Marc Coltrera; Yoshimi Anzai; Kenneth Krohn; Janet Eary
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2003-11
View more
  17 in total

1.  ¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.

Authors:  Sheng-Chieh Chan; Hung-Ming Wang; Tzu-Chen Yen; Chien-Yu Lin; Shy-Chyi Chin; Chun-Ta Liao; Yau-Yau Wai; Jiun-Jie Wang; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-13       Impact factor: 9.236

2.  Salvage surgery for head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

Review 3.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist.

Authors:  Jon Cacicedo; Arturo Navarro; Olga Del Hoyo; Alfonso Gomez-Iturriaga; Filippo Alongi; Jose A Medina; Olgun Elicin; Andrea Skanjeti; Francesco Giammarile; Pedro Bilbao; Francisco Casquero; Berardino de Bari; Alan Dal Pra
Journal:  Br J Radiol       Date:  2016-08-02       Impact factor: 3.039

4.  Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.

Authors:  Chih-Hua Yeh; Sheng-Chieh Chan; Chien-Yu Lin; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Kang-Hsing Fan; Hung-Ming Wang; Chun-Ta Liao; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-10-12       Impact factor: 9.236

Review 5.  Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.

Authors:  P Castaldi; L Leccisotti; F Bussu; F Miccichè; V Rufini
Journal:  Acta Otorhinolaryngol Ital       Date:  2013-02       Impact factor: 2.124

6.  PET/CT and 3-T whole-body MRI in the detection of malignancy in treated oropharyngeal and hypopharyngeal carcinoma.

Authors:  Shu-Hang Ng; Sheng-Chieh Chan; Tzu-Chen Yen; Chun-Ta Liao; Chin-Yu Lin; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Hung-Ming Wang; Kai-Ping Chang; Kang-Hsing Fan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-15       Impact factor: 9.236

7.  Head and neck squamous cell carcinoma (HNSCC)--detection of synchronous primaries with (18)F-FDG-PET/CT.

Authors:  Klaus Strobel; Stephan K Haerle; Sandro J Stoeckli; Madeleine Schrank; Jan D Soyka; Patrick Veit-Haibach; Thomas F Hany
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-02-10       Impact factor: 9.236

Review 8.  Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.

Authors:  Farzan Siddiqui; Min Yao
Journal:  World J Radiol       Date:  2014-06-28

9.  FDG-PET/CT identified distant metastases and synchronous cancer in squamous cell carcinoma of the head and neck: the impact of smoking and P16-s.

Authors:  Mogens Bernsdorf; Annika Loft; Anne Kiil Berthelsen; Julie Kjems; Ivan Richter Vogelius; Christian von Buchwald; Claus Andrup Kristensen; Anita Birgitte Gothelf; Jeppe Friborg
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-06-01       Impact factor: 2.503

10.  Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer.

Authors:  Maliha Sadick; Stefan O Schoenberg; Karl Hoermann; Haneen Sadick
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-12-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.